These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30157695)

  • 1. Risk-Based Monitoring: Key Conditions in Collaboration Between Contract Research Organization and Sponsor.
    Wolfs M; Bambic A; Lange BS; Galante K; Plaza RS; O'Conallain C; Racaro G; Giblin M; Djali S
    Ther Innov Regul Sci; 2019 Jul; 53(4):512-518. PubMed ID: 30157695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking the pulse of strategic outsourcing relationships.
    Getz KA; Lamberti MJ; Kaitin KI
    Clin Ther; 2014 Oct; 36(10):1349-55. PubMed ID: 25444564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical method transfer considerations of chromatographic-based assays.
    Williard CV
    Bioanalysis; 2016 Jul; 8(13):1409-13. PubMed ID: 27277876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
    DeCorte BL
    J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioanalytical outsourcing: transitioning from Pharma to CRO.
    Hayes R
    Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
    Abberley L
    Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
    [No Abstract]   [Full Text] [Related]  

  • 9. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
    Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S
    Clin Lung Cancer; 2018 Mar; 19(2):191-198. PubMed ID: 29153968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of Outsourcing Strategy and IT Technology in Clinical Trials.
    Stamenovic M; Dobraca A
    Acta Inform Med; 2017 Sep; 25(3):203-207. PubMed ID: 29114116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data Science Solution to Event Prediction in Outsourced Clinical Trial Models.
    Dalevi D; Lovick S; Mann H; Metcalfe PD; Spencer S; Hollis S; Ruau D
    Stud Health Technol Inform; 2015; 216():1065. PubMed ID: 26262364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical outsourcing: the two sides of the medal.
    Zimmer D
    Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioanalytical outsourcing strategy at Janssen Research and Development.
    Verhaeghe T
    Bioanalysis; 2014 May; 6(10):1321-7. PubMed ID: 24958116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.
    Hirsch IB; Martinez J; Dorsey ER; Finken G; Fleming A; Gropp C; Home P; Kaufer DI; Papapetropoulos S
    Clin Ther; 2017 May; 39(5):1064-1076. PubMed ID: 28413148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug development.
    Li W; Glick J; Hatsis P; Fu Y; Chin H; Moench P; Flarakos J
    Bioanalysis; 2021 Jun; 13(12):1001-1010. PubMed ID: 34081547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.